(Thinkstock photo)

U.S. begins testing bird flu vaccines for poultry after record outbreak

Four vaccines to be tested

Chicago | Reuters — The U.S. government is testing four potential bird flu vaccines for poultry, officials said on Friday, after more than 58 million chickens, turkeys and other birds have died in the nation’s worst outbreak ever. The trials, conducted by the U.S. Department of Agriculture’s (USDA) Agricultural Research Service, are the first step […] Read more

(PerformanceLivestockAnalytics.com)

Zoetis buys livestock data management firm

Performance Beef platform to expand drugmaker's 'precision' production offering

The producer of livestock drugs such as Draxxin, Bovatec and Excede is buying space in the “precision livestock farming” market with a deal for a U.S. livestock data management firm. New Jersey-based Zoetis, which makes drugs and vaccines for the beef and dairy cattle, equine, swine, poultry and sheep sectors as well as cats and […] Read more

Elanco CEO Jeff Simmons rings the ceremonial bell as the company’s stock begins trading on Sept. 20, 2018 at the NYSE. (Photo: Reuters/Brendan McDermid)

Animal health firm Elanco surges on trading debut

Reuters — Eli Lilly unit Elanco Animal Health’s shares jumped as much as 41 per cent on their stock market debut on Thursday, adding to investor enthusiasm for the fast-growing animal healthcare market. Elanco’s shares opened at $32.25 on the New York Stock Exchange, higher than their IPO price of $24 per share, giving the […] Read more


(Harrisvaccines.com)

Merck to buy Harrisvaccines to boost livestock portfolio

Chicago | Reuters — Merck and Co.’s animal health unit will buy privately-held Harrisvaccines to expand its portfolio of animal vaccines as the U.S. livestock industry seeks new defenses against diseases, the companies said on Thursday. Financial details were not disclosed. The deal, which is expected to close by year-end, follows rival Zoetis’ agreement, announced […] Read more